sq-11725 has been researched along with taurocholic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Brandl, M; Buckley, ST; Fischer, SM; Fricker, G; Kirchmeyer, W | 1 |
2 other study(ies) available for sq-11725 and taurocholic acid
| Article | Year |
|---|---|
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Application of simulated intestinal fluid on the phospholipid vesicle-based drug permeation assay.
Topics: Chemistry, Pharmaceutical; Cimetidine; Electric Impedance; Fluoresceins; Griseofulvin; Intestinal Secretions; Ketoprofen; Microscopy, Confocal; Nadolol; Permeability; Pharmaceutical Preparations; Phospholipids; Serum Albumin, Bovine; Taurocholic Acid; Technology, Pharmaceutical; Time Factors | 2012 |